IFP Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-332
| Closed | -$38.4K | – | 3296 |
|
|
2023
Q4 | $38.4K | Sell |
332
-700
| -68% | -$81.3K | ﹤0.01% | 1645 |
|
|
2023
Q3 | $119K | Hold |
1,032
| – | – | 0.01% | 1177 |
|
|
2023
Q2 | $106K | Hold |
1,032
| – | – | ﹤0.01% | 1294 |
|
|
2023
Q1 | $29.2K | Sell |
1,032
-926
| -47% | -$102K | ﹤0.01% | 1843 |
|
|
2022
Q4 | $78K | Sell |
1,958
-488
| -20% | -$40.5K | ﹤0.01% | 1923 |
|
|
2022
Q3 | $101K | Buy |
2,446
+239
| +11% | +$16.7K | ﹤0.01% | 1852 |
|
|
2022
Q2 | $96K | Hold |
2,207
| – | – | ﹤0.01% | 1711 |
|
|
2022
Q1 | $96K | Buy |
2,207
+1,134
| +106% | +$111K | ﹤0.01% | 1711 |
|
|
2021
Q4 | $116K | Buy |
1,073
+10
| +0.9% | +$1.09K | ﹤0.01% | 1204 |
|
|
2021
Q3 | $118K | Buy |
1,063
+3
| +0.3% | +$311 | ﹤0.01% | 1216 |
|
|
2021
Q2 | $99K | Sell |
1,060
-21
| -2% | -$1.93K | ﹤0.01% | 1252 |
|
|
2021
Q1 | $99K | Sell |
1,081
-45,341
| -98% | -$3.83M | ﹤0.01% | 1182 |
|
|
2020
Q4 | $3.4M | Sell |
46,422
-470
| -1% | -$34.9K | 0.14% | 123 |
|
|
2020
Q3 | $3.64M | Buy |
46,892
+2,027
| +5% | +$139K | 0.22% | 92 |
|
|
2020
Q2 | $2.48M | Buy |
44,865
+43,503
| +3,194% | +$1.86M | 0.2% | 111 |
|
|
2020
Q1 | $40K | Buy |
1,362
+276
| +25% | +$9.34K | ﹤0.01% | 1229 |
|
|
2019
Q4 | $40K | Buy |
1,086
+673
| +163% | +$20.6K | ﹤0.01% | 1351 |
|
|
2019
Q3 | $11K | Buy |
+413
| New | +$10.7K | ﹤0.01% | 2048 |
|
|
2019
Q1 | – | Sell |
-233
| Closed | -$5K | – | 3864 |
|
|
2018
Q4 | $5K | Sell |
233
-1,068
| -82% | -$20.9K | ﹤0.01% | 2898 |
|
|
2018
Q3 | $25K | Buy |
1,301
+1,283
| +7,128% | +$24.4K | ﹤0.01% | 2349 |
|
|
2018
Q2 | $0 | Buy |
+18
| New | +$274 | ﹤0.01% | 4181 |
|
|
2017
Q4 | – | Sell |
-100
| Closed | -$1K | – | 4275 |
|
|
2017
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 4018 |
|
|
2017
Q2 | $1K | Sell |
100
-1,845
| -95% | -$22.9K | ﹤0.01% | 4014 |
|
|
2017
Q1 | $29K | Sell |
1,945
-44
| -2% | -$713 | ﹤0.01% | 2272 |
|
|
2016
Q4 | $32K | Sell |
1,989
-6
| -0.3% | -$109 | ﹤0.01% | 2166 |
|
|
2016
Q3 | $36K | Sell |
1,995
-3,033
| -60% | -$59.3K | ﹤0.01% | 2021 |
|
|
2016
Q2 | $83K | Buy |
+5,028
| New | +$81.3K | ﹤0.01% | 1452 |
|
|
2016
Q1 | – | Sell |
-2,376
| Closed | -$51K | – | 3845 |
|
|
2015
Q4 | $51K | Buy |
+2,376
| New | +$46.3K | ﹤0.01% | 1620 |
|
Other funds holding HZNP
IFP Advisors's HZNP Position: Q1 2024 in Review
IFP Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2024, closing a stake of 332 shares — an estimated $38.4K sold.
IFP Advisors first reported a position in HZNP in Q4 2015 and held it in 28 quarters. The position peaked at $3.64M in Q3 2020. 1 fund tracked by Wall St. Rank holds HZNP as of Q1 2024.
- IFP Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2024 after selling out during the quarter.
- IFP Advisors sold 332 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2024, an estimated $38.4K.
- IFP Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 28 quarters.
- IFP Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.64M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2024.
Based on IFP Advisors's 13F filing for Q1 2024, filed 30 Jul 2024.